Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials

BACKGROUND: Many international guidelines on the prevention of venous thromboembolism recommend targeting heparin treatment at patients with stroke who have a high risk of venous thrombotic events or a low risk of haemorrhagic events. We sought to identify reliable methods to target anticoagulant tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Whiteley, William N, Adams, Harold P, Bath, Philip MW, Berge, Eivind, Sandset, Per Morten, Dennis, Martin, Murray, Gordon D, Wong, Ka-Sing Lawrence, Sandercock, Peter AG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671273/
https://www.ncbi.nlm.nih.gov/pubmed/23642343
http://dx.doi.org/10.1016/S1474-4422(13)70079-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671273/
https://www.ncbi.nlm.nih.gov/pubmed/23642343
http://dx.doi.org/10.1016/S1474-4422(13)70079-6

Ejemplares similares